High-risk myeloma: a gene expression–based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhan, Fenghuang, Barlogie, Bart, Mulligan, George, Shaughnessy, John D., Bryant, Barb
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2200846/
https://ncbi.nlm.nih.gov/pubmed/18182586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-10-119321
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados